Darou Pakhsh Pharma Chem

Name

Darou Pakhsh Pharma Chem

Legal name

Daroupakhsh Pharmaceutical Chemical Company (شرکت شیمی دارویی داروپخش)

Website

https://dppcco.com

Company type

Public

Founded year

1996

Operating status

Operating

Headcount range

101–250 employees

Short description

Darou Pakhsh Pharma Chem (DPPC) is an Iran-based public manufacturer of Active Pharmaceutical Ingredients, pellet products, and sterile injectable APIs. Listed on the Tehran Stock Exchange under TIPICO Pharmaceutical Holding, it serves domestic and export pharmaceutical markets.

Ownership category

akta.pro rank

Product category

Active Pharmaceutical Ingredients

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Small-Molecule API Commercial Manufacturing (HLAGAHAB)

akta.pro secondary industries

Generic APIs & Intermediates (Active Ingredients) (HLAIABAG), GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Active pharmaceutical ingredients
• Pharmaceutical chemical manufacturing
• API production
• Pharmaceutical raw materials
• Controlled release pellets

Headquarters

HQ city

Taleghan

HQ country

Iran

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Active Pharmaceutical Ingredient (API) Sales: Manufacture and sale of pharmaceutical raw materials including general APIs, LVHV APIs, injectable-grade APIs, and pellet products to domestic pharmaceutical companies and export markets.
2. Toll Manufacturing (Commissioned Production): Contract/toll manufacturing services producing APIs and semi-finished pharmaceutical materials for other companies within the TIPICO group and external clients.
3. R&D and Development Services: Development of new API products with registered 26 knowledge-based products and 14 R&D projects valued at 25 billion Tomans entered tax credit evaluation phase.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Darou Pakhsh Pharma Chem manufactures and sells Active Pharmaceutical Ingredients (APIs) for the pharmaceutical industry. The company produces general APIs, Low Volume High Value (LVHV) APIs, injectable-grade sterile APIs, and pharmaceutical pellet products for controlled-release formulations, supplying both domestic Iranian pharmaceutical manufacturers and export markets through GMP-certified production facilities.

Product overview

Darou Pakhsh Pharma Chem operates as a pharmaceutical manufacturer producing Active Pharmaceutical Ingredients (APIs) organized into four main product lines: API-General (general-purpose APIs across cardiovascular, anti-inflammatory, antibiotic, gastrointestinal, and neurological therapeutic categories), Pellet Products (controlled-release pharmaceutical pellets), API-LVHV (high-value low-volume specialized APIs), and API-Injectable (sterile-grade APIs for injectable drug manufacturing). The company holds 82 production licenses and 26 knowledge-based products, positioning itself as one of Iran's most diversified API manufacturers with products spanning over 45 compounds including combination formulations of Clavulanate Potassium with Amoxicillin and microcrystalline cellulose.

Differentiator

Problem solved

Functional benefit

Products and services

• API-General General Active Pharmaceutical Ingredients covering cardiovascular, anti-inflammatory, antibiotic, gastrointestinal, neurological and psychiatric therapeutic categories including Atenolol, Azithromycin, Captopril, Diclofenac Sodium, and others.
• Pellet Products Pharmaceutical pellets for controlled and effective release of active ingredients, including Orlistat, Tamsulosin, Diclofenac Sodium, Duloxetine, and Fenofibrate in various concentrations.
• API-LVHV High-Value, Low-Volume Active Pharmaceutical Ingredients for specialized and specialty drugs including Repaglinide, Memantine, Donepezil, Solifenacin, and Varenicline.
• API Injectable Sterile Active Pharmaceutical Ingredients for manufacturing injectable drugs meeting global standards, including Granisetron Hydrochloride, Ondansetron Hydrochloride, Ketorolac Tromethamine, and others.

Quantifiable outcome

• 127% increase in net profit (from 822 to 1,866 billion Rials) in fiscal year 1404
• +3 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• TIPICO Pharmaceutical Holding (شرکت سرمایه‌گذاری دارویی تأمین)coreStrategic or Co-development PartnerTIPICO (Tamin Pharmaceutical Investment Company) is the parent pharmaceutical holding company under which Darou Pakhsh Pharma Chem operates as a subsidiary. The company is listed on the Tehran Stock Exchange and is an integral part of TIPICO's pharmaceutical value chain, contributing to the group's strategy of domestic API production and pharmaceutical self-sufficiency.

Scale indicators11 records

Recent moves8 records

Expansion highlights4 records

Broad incumbents

• Dr. Reddy's Laboratories: Integrated Indian pharmaceutical company with substantial API manufacturing operations and global formulations business. Comparable on API manufacturing scale, GMP certifications, and regulatory depth across multiple therapeutic categories.
• Cipla: Major Indian pharmaceutical manufacturer with significant API manufacturing capability spanning respiratory, anti-retroviral, and other therapeutic areas. Comparable on GMP-certified multi-site API production and international market reach.
• Teva Pharmaceutical Industries: Israel-headquartered global generic pharmaceutical leader with one of the world's largest API manufacturing footprints. Comparable on broad small-molecule API portfolio and GMP-certified multi-site manufacturing, though at much larger scale.
• Sun Pharmaceutical Industries: India's largest pharmaceutical company with extensive API and finished dosage form manufacturing. Comparable on diversified API portfolio, GMP-certified multi-site operations, and global export orientation.
• Aurobindo Pharma: Major India-headquartered generic pharmaceutical and API manufacturer with broad therapeutic coverage. Directly comparable as a large-scale, multi-product small-molecule API manufacturer targeting global markets, particularly relevant given DPPC's CPHI India export push.

Direct peers

• Natco Pharma: Indian pharmaceutical firm with API manufacturing capabilities and specialty focus on complex generics and oncology. Comparable on portfolio breadth across APIs and on GMP manufacturing depth in differentiated dosage-form categories.
• Laurus Labs: Indian API and formulations manufacturer with strong position in small-molecule APIs and ARV therapeutic categories. Comparable as a growing, knowledge-driven API manufacturer expanding into complex and specialty API categories.
• Divis Laboratories: India-based pure-play API manufacturer specializing in complex generics and active ingredients. Closely comparable business model as a focused, GMP-certified commercial API manufacturer with global export orientation.
• Ipca Laboratories: Indian pharmaceutical company focused on APIs and formulations with strong domestic and export presence. Comparable as a mid-sized API manufacturer with diversified therapeutic coverage and GMP-certified facilities.
• Hikal: India-based API and contract manufacturer serving global pharmaceutical companies. Comparable as a B2B API and CDMO provider with GMP-certified facilities and an export-oriented GTM motion.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/darou-pakhsh-pharma-chem
• Instagraminstagram.com/dppc.co
• Facebookfacebook.com/Darou-Pakhsh-Pharma-Chem-Co-217395755416134

Compliance14 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Darou Pakhsh Pharma Chem